Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma



Status:Completed
Conditions:Breast Cancer, Lung Cancer, Liver Cancer, Cancer, Brain Cancer, Blood Cancer, Lymphoma, Hematology
Therapuetic Areas:Hematology, Oncology
Healthy:No
Age Range:18 - Any
Updated:11/19/2017
Start Date:July 20, 2010
End Date:December 9, 2016

Use our guide to learn which trials are right for you!

A Phase 1/2, Multi-Center, Open-Label, Dose Finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the mTOR Kinase Inhibitor CC-223 Administered Orally to Subjects With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Multiple Myeloma

The main purpose of this first human study with CC-223 is to assess the safety and action of
a new class of experimental drug (dual mTOR inhibitors) in patients with advanced tumors
unresponsive to standard therapies and to determine the appropriate dose and tumor type for
later-stage clinical trials.

Initially, patients will be treated with oral CC-223 for one month. During this time, various
tests (involving blood and urine collections, ECGs, etc) will be performed. Those whose
tumors stabilize or regress may continue receiving treatment for as long as they benefit from
CC-223. Different dose levels of CC-223 will be tested in a dose-rising study design.

Inclusion Criteria:

- Histologically-confirmed advanced solid tumor, Non-Hodgkin Lymphoma or multiple
myeloma

- Patients have not tolerated or progressed on standard therapy, and no further standard
therapy is available

- Archival and screening tumor biopsy

- Eastern Cooperative Oncology Group (ECOG) performance status 0-1 (solid tumors), 0-2
(hematologic malignancy)

- Adequate organ function

Exclusion Criteria:

- Prior systemic cancer-directed treatments or investigational drugs within 4 weeks or 5
half lives, whichever is shorter, prior to starting study drug or who have not
recovered from side effects of such therapy. Subjects must have recovered from any
effects of recent radiotherapy that might confound the safety evaluation of study drug

- Symptomatic brain metastases (prior Rx and stable metastases are OK)

- Acute or chronic liver or renal disease or pancreatitis

- Diarrhea ≥ Grade 2, impaired GI absorption

- Impaired cardiac function

- Diabetes requiring Rx, glucose >126 mg/dL, HbA1c ≥6.5%

- Peripheral neuropathy ≥ Grade 2

- Pulmonary fibrosis

- Known HIV infection

- Known chronic hepatitis B or C virus (HBV/HCV) infection, unless comorbidity in
subjects with HCC

- Pregnant, inadequate contraception

- Most concurrent second malignancies
We found this trial at
11
sites
?
mi
from
Nashville, TN
Click here to add this to my saved trials
8700 Beverly Blvd # 8211
Los Angeles, California 90048
(1-800-233-2771)
Cedars Sinai Med Ctr Cedars-Sinai is known for providing the highest quality patient care. Our...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
801 North 29th Street
Billings, Montana 59107
406-238-2500
Billings Clinic Based in Billings, Montana, Billings Clinic is a community-governed health care organization consisting...
?
mi
from
Billings, MT
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
30 Prospect Ave
Hackensack, New Jersey 07601
(201) 996-2000
Hackensack University Medical Center Hackensack University Medical Center, part of the Hackensack University Health Network,...
?
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Los Angeles, California 90095
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
New York, New York 10016
?
mi
from
New York, NY
Click here to add this to my saved trials
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Tampa, Florida 33612
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Toulouse Cedex, 31052
?
mi
from
Toulouse Cedex,
Click here to add this to my saved trials